Prof. Dr. Andreas Mackensen



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

CD19-CAR T-cell therapy induces deep tissue depletion of B cells (2024) Tur C, Eckstein M, Velden J, Rauber S, Bergmann C, Auth J, Bucci L, et al. Journal article The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany (2024) Krebs M, Haller F, Spörl S, Gerhard-Hartmann E, Utpatel K, Maurus K, Kunzmann V, et al. Journal article CAR T-cell perspectives in lupus – Authors' reply (2024) Schett G, Mackensen A, Mougiakakos D Journal article Selective CAR T cell–mediated B cell depletion suppresses IFN signature in SLE (2024) Wilhelm A, Chambers D, Müller F, Bozec A, Grieshaber Bouyer R, Winkler T, Mougiakakos D, et al. Journal article CAR T-Cell Therapy in Autoimmune Disease. Reply. (2024) Müller F, Mackensen A, Schett G Journal article, Letter CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis (2024) Krickau T, Naumann-Bartsch N, Aigner M, Kharboutli S, Kretschmann S, Spörl S, Vasova I, et al. Journal article CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab. (2024) Biedermann A, Patra-Kneuer M, Mougiakakos D, Büttner-Herold M, Mangelberger-Eberl D, Berges J, Kellner C, et al. Journal article Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disorders (2024) Mougiakakos D, Sengupta R, Gold R, Schroers R, Haghikia A, Lorente M, Pendleton M, et al. Journal article Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell-depleting antibodies: reply. (2024) Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kretschmann S, Atzinger A, et al. Journal article